“Assessment of Dapagliflozin Effectiveness As Add-on Therapy for the Treatment of Type 2 Diabetes Mellitus ”. 2022. Academia Journal of Medicine 4 (2): 50-54. https://medjournal.co.in/index.php/ajm/article/view/82.